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The transition from commensalism to pathogenicity of Candida albicans reflects both the 
host inability to mount specific immune responses and the microorganism’s dimorphic 
switch efficiency. In this study, we used whole genome sequencing and microarray 
analysis to investigate the genomic determinants of the phenotypic changes observed in 
two C. albicans clinical isolates (YL1 and YQ2). In vitro experiments employing epithelial, 
microglial, and peripheral blood mononuclear cells were thus used to evaluate C. albi-
cans isolates interaction with first line host defenses, measuring adhesion, susceptibility 
to phagocytosis, and induction of secretory responses. Moreover, a murine model of 
peritoneal infection was used to compare the in vivo pathogenic potential of the two 
isolates. Genome sequence and gene expression analysis of C. albicans YL1 and 
YQ2 showed significant changes in cellular pathways involved in environmental stress 
response, adhesion, filamentous growth, invasiveness, and dimorphic transition. This was 
in accordance with the observed marked phenotypic differences in biofilm production, 
dimorphic switch efficiency, cell adhesion, invasion, and survival to phagocyte-mediated 
host defenses. The mutations in key regulators of the hyphal growth pathway in the 
more virulent strain corresponded to an overall greater number of budding yeast cells 
released. Compared to YQ2, YL1 consistently showed enhanced pathogenic potential, 
since in vitro, it was less susceptible to ingestion by phagocytic cells and more efficient 
in invading epithelial cells, while in vivo YL1 was more effective than YQ2 in recruiting 
inflammatory cells, eliciting IL-1β response and eluding phagocytic cells. Overall, these 
results indicate an unexpected isolate-specific variation in pathways important for host 
invasion and colonization, showing how the genetic background of C. albicans may 
greatly affect its behavior both in vitro and in vivo. Based on this approach, we propose 
that the co-occurrence of changes in sequence and expression in genes and pathways 
driving dimorphic transition and pathogenicity reflects a selective balance between traits 
2Cavalieri et al. Pathogenic Strategies of C. albicans
Frontiers in Immunology | www.frontiersin.org January 2018 | Volume 8 | Article 1997
favoring dissemination of the pathogen and traits involved in host defense evasion. This 
study highlights the importance of investigating strain-level, rather than species level, 
differences, when determining fungal–host interactions and defining commensal or 
pathogen behavior.
Keywords: Candida albicans, host adaptation, biofilm, pathogenic traits, genomic, fungal isolates, phagocytes
and low virulent strains, with differences in metabolic pathways, 
such as the phosphate metabolism, known to have an important 
role in pathogenesis (8). One of the most potent virulence 
traits of C. albicans in  vivo is its morphogenetic plasticity that 
allows fungal transition from yeast-to-hyphal forms, depend-
ing on environmental cues, such as morphogens (i.e., pH, CO2, 
temperature, presence of serum, and other micronutrients) (19). 
In particular, dimorphic transition to hyphal forms is crucial in 
promoting fungal escape from phagocytes (20–22), by reducing 
phagocyte-mediated ingestion and intracellular killing, a process 
crucial in infection control being pivotal to the accomplishment 
of both innate and adaptive immunity. Moreover, it is noteworthy 
that, from an evolutionary standpoint, both yeast and hyphal cells 
are required to sustain pathogenicity and host invasion, in fact 
neither yeast cell blocked strains nor hyper-filamentous mutants 
are fully virulent in experimental systemic infections (23–25).
In this study, we investigated the genomic determinants of the 
phenotypic changes observed in two C. albicans clinical isolates 
from Crohn’s disease (CD) patients. We probed their adaptation 
to the host by means of an in vitro infection model that employed 
different host cells, such as epithelial cells, peripheral blood 
mononucleated cells (PBMCs), and tissue-derived macrophages, 
namely microglial cells, known to play a major role as anti-
Candida effector cells in  vitro, as well as in  vivo in preventing 
the outcome of experimental meningoencephalitis by C. albicans 
(26–28). Finally, we explored the pathogenic potential of such 
isolates in vivo by a murine model of peritoneal infection.
MaTerials anD MeThODs
Fungal strains and culture conditions
The clinical isolates of C. albicans used in this study, named YL1 
and YQ2, were obtained from fecal samples of two pediatric CD 
patients in clinical remission, but having mucosal inflammation. 
C. albicans reference strain SC5314 (ATCC® MYA-2876™) was 
also used in some experiments, as a control. Long-term storage 
of the isolates was carried out in 20% glycerol at −80°C. For 
phenotypic characterization and extraction of genomic DNA 
for whole-genome sequencing, YL1 and YQ2 yeast cells were 
seeded in liquid culture [Yeast Peptone Dextrose (YPD), with 
1% yeast extract, 2% peptone, 2% glucose] at 28°C. For host–
fungal interaction studies, fungal cells were cultured overnight 
at 37°C in Saboraud dextrose agar (SDA, Oxoid, Hampshire, 
UK); then, yeast cells were harvested, washed twice with sterile 
phosphate-buffered saline (PBS) (EuroClone, Wetherby, UK), 
counted and suspended in RPMI 1640 medium at the desired 
concentration.
inTrODUcTiOn
Fungi belonging to Candida genus are commonly harbored in up 
to 80% of human population, being the most prevalent commensal 
species inhabiting skin, gastrointestinal, and urogenital mucosae 
(1). Nevertheless, Candida spp. may give rise to opportunistic 
infections in susceptible hosts, such as in immunocompromised 
individuals (2), where they are responsible for the majority of 
mucosal and deep-seated candidiasis (3–5), or skin/mucosal 
barriers are affected, such as in extensively hospitalized and/or 
surgical patients where health care-associated candidemia often 
occur (6). This is an exponentially increasing threat, in particular, 
with the rise of azole resistant strains.
Genome-wide surveys of the microorganisms inhabiting the 
different human body microenvironments (i.e., gut, skin, oral 
mucosa, and urogenital tract) (7) have suggested the presence 
of strong and selective control on microbial communities that 
colonize and persist in peculiar environments. C. albicans effica-
ciously adapts to its host by escaping immune system recognition/
detection (8, 9), as well as by acquiring specific drug-resistance 
(10, 11). The nature and extent of such changes have been studied 
ex vivo employing clinical or environmental isolates. Differences 
in cell wall composition have been accounted for escape from 
Dectin-1 (12, 13) or even TLR4 (14) recognition. Recently, 
Schönherr and collaborators explored the host immune response 
to different clinical C. albicans isolates (9), showing how fungal 
diversity determines diverse immune outcomes, where a delayed 
induction of Th17 response allows C. albicans colonization, while 
isolates inducing an immediate and strong Th17 response are 
rapidly cleared.
Different molecular typing approaches, including multilocus 
sequence typing (15, 16) and DNA fingerprinting (17) helped 
in unraveling the epidemiology and population structure of 
C. albicans (18). In particular, extensive plasticity of C. albicans 
genome has been documented, consisting of multiple major and 
minor clades, some of which showing a geographical imprint-
ing. Although C. albicans isolates tend to show clonal origin, 
recombination and cross-chromosomal rearrangements may 
occur and appear more common under environmental stress 
conditions, such as prolonged drug treatments or exposure to 
host immune defenses; likely, these phenomena play a significant 
role in promoting microevolution and in turn virulence of this 
opportunistic pathogen.
Different fungal isolates of clinical origin vary in adhesion, 
dimorphic transition, and virulence (8, 10, 12), revealing an 
intriguing microbial adaptation possibly acting as an immune 
evasion strategy. In vivo and in  vitro analysis of isolates from 
oral candidiasis has allowed identification of high, intermediate, 
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Whole genome analysis
Whole genome sequencing was carried out using the Illumina 
Genome Analyzer IIx (GAIIx) platform, and HiSeq2000 sequenc-
ing instrument. The standard Illumina protocol with minor 
modifications was followed for the creation of short-insert paired- 
end libraries (Illumina, Inc.). In brief, 2.0 µg of genomic DNA 
was sheared on a Covaris™ E220. The ~500 bp fragmented DNA 
was end-repaired, adenylated, and ligated to Illumina specific 
paired-end adaptors. To obtain a library of very precise insert 
size (500 bp) with the size deviation of ±25 bp, the DNA with 
adaptor-modified ends was size selected and purified using the 
E-gel agarose electrophoresis system (Invitrogen). After size 
selection, the library was PCR amplified using 10 PCR cycles. 
To create another library, at the same protocol above were added 
also a step at 72°C before adaptor ligation and a rapid cooling 
down to 4°C. This procedure allowed us to improve the coverage 
of increased GC-content regions of the genome. Each library was 
run in a fraction of a GAIIx flowcell lane in paired end mode of 
2 × 151 bp read length, using Sequencing kit v4, or on HiSeq2000 
in 2 × 101 bp read length, using TruSeq SBS Kit v3, both accord-
ing to standard Illumina operation procedures (Illumina, Inc.). 
Primary data analysis was carried out with the standard Illumina 
pipeline. The purity of the signal from each cluster was exam-
ined over the first 25 cycles and chastity =  Highest_Intensity/
(Highest_Intensity  +  Next_Highest_Intensity) was calculated 
for each cycle. To remove the least reliable data from the analysis, 
reads were filtered according to chastity >0.6, for all but one of the 
first 25 bases. If there were two bases, the read was subsequently 
removed.
illumina Quality control and snP calling
Sequence data are available at http://www.ebi.ac.uk/ena/data/
view/ERP002505, under the accession number ERP002505. 
Illumina reads were subjected to quality control (filtering and 
trimming) using QC Toolkit (29). Paired reads were filtered with 
parameters: −l 70 (cutOffReadLen4HQ) and −s 20 (cutOffQualS-
core). As a result, reads with a PHRED quality score of less than 
20 for more than 30% of their length were discarded. Moreover, 
reads were trimmed at the 3′ end for bases with a PHRED quality 
score of less than 30. Paired reads were mapped to the reference 
genomes [C. albicans SC5314, REfSeq NZ_AACQ00000000.1 
(Stanford University), and WO-1, RefSeq AAFO00000000.1 
(Broad Institute)], using Burrows Wheeler Aligner (BWA).1 The 
Genome Analysis Toolkit (GATK) was used for base quality 
score recalibration, Indel realignment, duplicate removal, and to 
perform SNP and Indel (insertion or deletion) discovery (30).
Variant imposition
The coding sequences of C. albicans YL1 and YQ2 isolates were 
created using variant imposition (a.k.a. consensus calling) in 
order to create uniform sets of genes for further analysis. Briefly, 
this technique inserted variants (SNPs and Indels) produced by 
GATK and specific for each strain into the coding sequences 
of the reference strains (SC5314 and WO-1) to create accurate 
1 http://bio-bwa.sourceforge.net/.
coding DNA sequence (CDS) useful for phylogenetic comparison 
across strains.
gene loss Prediction and gene Ontology 
enrichment of lost, Duplicate, Truncated 
genes
For each isolate, the alignments (BWA, then optimized by GATK) 
of reads vs the reference genome were analyzed and CDSs (taken 
from the genomic coordinates of SC5314 reference strain and 
reassembled in case of multiple exons) evidencing a zero cover-
age in at least one position were called as “lost.” In fact, these 
genes were apparently non-functional, broken, or lacked evident 
similarity with the reference. We considered that only a minority 
of genes (around 10%) had some positions (<5) with a cover-
age equal to 0. Although possibly affected by technical errors, 
especially in genes belonging to regions with low complexity or 
repetitive sequences that could be difficult to align, we considered 
this approach a valuable source of information and that false posi-
tive genes should appear in the majority of the strains analyzed 
and could be either false positives or acquisitions of the reference 
genome. Gene Ontology Term Finder tool on Candida Genome 
Database (CGD)2 were used for Functional Enrichment Analysis, 
using default parameters (therefore, considering as valid results 
with a p-value <0.05).
cell Wall extraction and sugars 
Quantification
The sugar composition of cell walls was analyzed as previously 
described (31). After sample preparation, monosaccharide analy-
sis and quantification was performed using high-performance 
anion-exchange chromatography coupled with pulsed electro-
chemical detection (HPAEC-PAD) according to Dallies et  al. 
(32). Glucose (for glucan content determination), mannose 
(mannan content), and glucosammine (for chitin) were identified 
by comparison with standard compounds and quantified accord-
ing to calibration curves obtained for each sugar.
Transcriptional analysis
Candida albicans YL1 and YQ2 strains have been plated at a 
concentration of 1 × 107 cell/ml in complete RPMI in presence 
or absence of 10% fetal bovine serum (FBS). RNA was isolated at 
1 and 24 h from collected cells by the hot acid phenol extraction 
protocol. cDNA was synthesized from 200  ng of total RNA by 
reverse transcription using the one color Agilent kit (Quick Amp 
Labeling, Agilent Technologies, Santa Clara, CA, USA). Custom 
gene expression microarrays were provided by Agilent (Design 
ID 065138). Each condition tested was analyzed in triplicate. 
Microarrays were scanned with the Agilent scanner and primary 
analysis was carried out using the Feature extraction analysis soft-
ware (Agilent Technologies). The LIMMA Bioconductor package 
on R was subsequently used for the data analysis. Locally weighed 
linear regression analysis was performed to normalize within 
arrays, and quantile normalization was carried out among arrays.
2 http://www.candidagenome.org/.
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Comparisons have been performed between the different 
genetic backgrounds at the same time point. Differentially 
expressed genes (DEGs) were calculated by fitting a linear 
model to the data, followed by empirical Bayes statistics. 
Genes with p-value lower than 0.05 were considered to be 
significantly differentially expressed compared to the different 
condition. Data were expressed as fold change in logarithmic 
scale. Microarray data are public available to the GEO reposi-
tory, under the accession number GSE85138. DAVID (33) and 
FungiFun 2.0 tools (34) were used for Functional Enrichment 
Analysis on DEGs, using default parameters (therefore 
considering as valid results with a p-value <0.05). Heatmap 
visualization of differential expressed genes, supported by 
hierarchical clustering (obtained using distance metric selec-
tion by Pearson correlation and average linkage clustering 
methods) was performed by Multiple Experimental Viewer 
tool (35).
Phenotypical characterization
Hyphal Formation
Yeast cells (106  cells/ml) were grown in liquid YPD and YNB 
(0.67% Yeast Nitrogen Base w/o amino acids and (NH4)2SO4 and 
2% glucose) media, both at 28°C and 37°C. After 3 and 7 days 
of incubation, hyphal formation was microscopically evaluated.
Resistance to Oxidative Stress
Yeast cell resistance to oxidative stress was evaluated by meas-
uring the inhibition halo, as detailed elsewhere (36); briefly, 
C. albicans YL1 and YQ2 yeast cells (107 cell/ml) were exposed 
to tert-Butyl-hydroperoxide (tBut-OOH) 1  M. After 5  days 
of incubation at 28°C, the inhibition halo diameters (Ø) were 
measured. The percentage of sensitivity to oxidative stress was 
evaluated comparing the Ø of the clinical isolates with those of 
the reference SC5314 C. albicans strain.
Invasive Growth Assay
The ability of YL1 and YQ2 isolates to penetrate solid standard 
medium (YPD) was tested, as detailed elsewhere (37). Briefly, 
yeast cells (104  cells/ml) were spotted on solid YPD plates and 
incubated at 28°C and 37°C. After 5 days of growth, cultures were 
stained with Coomassie blue and invasive growth was visually 
evaluated as signs of penetration onto the blue colored agar. The 
SC5314 C. albicans strain was used as positive control.
Growth on Different Carbon Sources
Candida albicans YL1 and YQ2 yeast cells (106  cells/ml) were 
grown in solid YP added with the following carbon sources (2%): 
glucose, galactose, glycerol, ethanol, sucrose, oleate; the survival 
was evaluated after 3 days by colony-forming units (CFU) assay.
Antifungal Drug Resistance
Antifungal drug resistance was performed evaluating the growth 
of yeast cells (106  cells/ml) in solid YPD added with different 
concentration of fluconazole and ketoconazole (0.01, 0.1, 0.5, 1, 
and 5 mM for each drug). SC5314 was used as control. Colony 
formation was evaluated after 24, 48, and 72 h of growth at 28°C.
human epithelial cells
The human epithelial colorectal adenocarcinoma cell line 
Caco-2 (ATCC® HTB-37™) was grown in 75-cm2 tissue-culture 
flasks (Nalgen Nunc International, Naperville, IL, USA), using 
Dulbecco’s Modified Eagle’s Medium (EuroClone, Milan, 
Italy) supplemented with 10% heat-inactivated FBS, 2  mM 
l-glutamine, and 50 mg/ml gentamycin. Just before confluence, 
Caco-2 cell cultures were split 1:3 by standard methods. The 
cell cultures were maintained at 37°C under 5% CO2. Cells 
were seeded at a concentration of 6.5 × 105/ml for the adhesion 
experiments and at a concentration of 8 × 105/ml for the secre-
tion assay.
human Peripheral Blood Mononuclear 
cells isolation, exposure to Candida, and 
cytokine Detection
The experimental plan was approved by the local Ethical Commi-
ttee of Azienda Universitaria Ospedaliera Careggi (AUOC, 
Care ggi Hospital, Florence; Italy), and written informed consent 
was obtained from all donors (approval document n. 87/10). 
Peripheral Blood Mononuclear Cells (PBMCs) were isolated 
from buffy coat samples by Ficoll-Hypaque density gradient 
centrifugation (Biochrom AG). Cells (106 cells/ml) were cultured 
in RPMI 1640 medium supplemented with 10% heat-inactivated 
FBS, 2 mM l-glutamine, at 37°C under 5% CO2. YL1 or YQ2 cells 
were added to PBMCs cells at a E:T ratio of 1:10.
Supernatants were collected 5 days later for cytokine detec-
tion and conserved at −20°C until assayed. Cytokine detection 
was performed using the Milliplex® MAP human cytokine/
chemokine kit (Millipore), according to the manufacturer’s 
instructions.
Phagocytosis assay
In vitro phagocytosis assay has been performed as previously 
performed (38) with slight modification, according to the micro-
organism used. Briefly, BV2 cells (2 × 106/ml, 100 µl/well) were 
seeded on poly-l-lysinated Lab-Tek II chamber slides (Nalgen 
Nunc International), incubated for 15  min at 37°C under 5% 
CO2 and then exposed to C. albicans YL1 or YQ2 yeast cells 
(4 × 106/ml, 100 µl/well), suspended in complete RPMI [effector 
to target (E:T) ratio of 1:2]. The BV2 cells were further incubated 
for 1.5 or 3 h at 37°C under 5% CO2, as previously performed. 
Fifteen minutes before the end of incubation, Uvitex 2B 
(40 µl/well, Polisciences, Inc., PA, USA) was added, as a fluores-
cent dye that binds to fungal cell chitin (39, 40). BV2 cells were 
then washed three times with PBS to remove extracellular yeasts 
and fixed for 30 min with 4% paraformaldehyde (PFA) (Sigma-
Aldrich) in PBS. ProLong Gold Antifade Reagent (PLGAR, 
Molecular Probes, Invitrogen, St. Louis, MO, USA) has been used 
to suppress the photobleaching effect and preserve the signals of 
labeled target molecules. The blue fluorescent Candida bound to 
BV2 cells as well as the unlabeled internalized fungi were visual-
ized by epifluorescence microscopy (Nikon Instruments). At least 
200 microglial cells from each sample were examined and the 
percentage of phagocytic cells (cells with intracellular yeasts) was 
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defined as the ratio between the number of BV2 cells contain-
ing one or more unlabeled Candida to the total number of cells 
considered.
Microglial cells
The previously established murine microglial cell line BV2 was 
maintained by biweekly passages, as previous described (41) in 
RPMI 1640 medium supplemented with 10% heat-inactivated 
FBS gentamicin (50  mg/ml; Bio Whittaker, Verviers, Belgium) 
and l-glutamine (2  mM; EuroClone, Milan, Italy), hereafter 
referred to as just “complete RPMI medium.” The day before each 
experiment, cells were detached by vigorous shaking and seeded 
in fresh complete RPMI medium, at a concentration of 5 × 105/
ml on the day before each experiment.
epifluorescence Microscopy
Epifluorescence and differential interference contrast (DIC) micro-
scopy were performed, as previously described (38), by using a 
Nikon Eclipse 90i imaging system, equipped with Nomarski DIC 
optics (Nikon Instruments Inc., USA). At each time point, sam-
ples were photographed with a DS-2Mv Nikon digital camera, 
and the resulting microphotographs were analyzed by using the 
Nikon NIS ELEMENTS version D3.1 software.
Phagolysosome acidification assay
Visualization of the acidic Candida-containing phagosomes was 
performed as described previously (42), using the acidotropic 
dye LysoTracker Red DND-99 (Molecular Probes, Invitrogen) 
at a final concentration of 5 mM. The internalized Candida cells 
(no fluorescence) were visualized by epifluorescence microscopy 
(as opposed to bound/un-ingested yeast cells that showed a blue 
fluorescence because of the Uvitek 2B labeling). Acidification 
of the Candida containing phagosomes was indicated by the 
simultaneous appearance of LysoTracker Red DND-99 (red fluo-
rescence) and Candida cells within the phagosomes that resulted 
as red fluorescence when merging the images. For quantitative 
analysis, the percentage of acidic phagosomes per image was cal-
culated as the number of red phagosomes within the phagocytic 
cells divided by the total number of internalized Candida cells 
(unlabeled yeasts).
intracellular survival assay
The assay has been performed as previously described (43), with 
some modifications. Briefly, BV2 cells (2 × 106/ml, 5 × 106/2.5 ml) 
were incubated in 25-cm2 tissue-culture flasks (Nalgen Nunc 
International, Naperville, IL, USA) for 1.5  h with YL1 or YQ2 
yeast cells (4 × 106/ml, 107/2.5 ml) in complete RPMI medium, at 
an E:T ratio of 1:2. Cells were harvested, washed twice with PBS, 
suspended in complete RPMI (time 0), and then seeded in 24-well 
polystyrene plates (Nalgen Nunc International, Naperville, IL, 
USA). At 0, 3, 6, and 20 h postinfection, the BV2 cells were lysed 
with 0.2% (v/v) Triton X-100 for 15 s to release the intracellular 
Candida. Serial dilutions were then plated onto SDA medium 
and CFUs were counted after 24 h incubation. The results were 
expressed as survival index (SI) at different time points. The SI 
was calculated as the ratio between CFU counts detected at 3, 6, 
and 20 h and the CFU counts obtained at time 0. Control experi-
ments were carried out to verify that the treatment with Triton 
X-100 was not toxic for the Candida (data not shown).
adhesion assay
Caco-2 cells (1.3 ×  105/200 μl, 6.5 ×  105/ml, 200  µl/well) were 
seeded in Lab-Tek II chamber slides, grown at 37°C to confluence 
(24 h), and then infected with a suspension of C. albicans YL1 or 
YQ2 yeast cells (5.2 × 105/200 μl, 2.6 × 106/ml, 200 µl/well) in 
complete RPMI (E:T ratio of 1:2). Caco-2 cells were incubated for 
1.5 or 3 h at 37°C under 5% CO2. Fifteen min before the end of the 
incubation, samples were treated with Uvitex 2B (1%, 40 µl/well), 
washed three times with PBS to remove unbound yeast cells, and 
fixed for 30 min with PBS-buffered 4% PFA. After washing with 
PBS, Caco-2 cells were treated with PLGAR. The adherent C. albi-
cans cells (blue fluorescence) were visualized by epifluorescence 
microscopy. At least 200 epithelial cells from each sample were 
examined and the percentage of adhesion was defined as the ratio 
between the number of Caco-2 cells with one or more C. albicans 
and the total number of Caco-2 cells examined.
secretory assay
Caco-2 cells were seeded in 24 well-plates and incubated for 24 h 
to reach confluency. Then, C. albicans YL1 and YQ2 yeast cells 
(E:T ratio of 1:100) were added and plates were further incubated 
for additional 6 and 24 h. Cell-free supernatants were then col-
lected and the levels of β-2 defensin was assessed by means of 
an enzyme immunoassay [β-2-Defensin (Human), Phoenix 
Pharmaceuticals Inc., Karlsruhe, Germany].
Biofilm Formation
Candida albicans YL1 and YQ2 yeast cells were grown overnight 
in SDA plates at 37°C. Cells were harvested, washed with PBS, 
and suspended at 1 × 105 or 1 × 106 yeast cells/ml in complete 
RPMI. Then, 100 µl aliquots of each yeast cell suspension were 
placed in 96-well polystyrene microplates and incubated at 37°C 
for 24 and 48 h. After incubation, biofilm formation was quanti-
fied by the crystal violet assay, according to previously described 
protocols (22). To evaluate fungal dispersal from the biofilm, at 
48 h, 100 µl/well were harvested and then the number of both 
yeasts and budding yeast cells were directly counted by a Burker 
chamber.
Biofilm Thickness Measurement
Candida albicans YL1 and YQ2 yeast cells were seeded in six well-
plates (Nalgen Nunc International), at 106 cells/ml in complete 
RPMI and incubated for 24 and 48 h (37°C, 5% CO2). Then, wells 
were washed with PBS at room temperature, fixed with 4% PFA 
for 30 min at 4°C, and delicately washed again with cold PBS to 
remove PFA. The plates were then placed upside down and allowed 
to dry for 1 h. The samples were finally visualized using an optical 
microscope (Nikon Instruments Inc., USA). To measure biofilm 
thickness, the microscope sample tray was regularly moved 
(2 µm steps up) along the vertical axis, starting from the biofilm 
bottom (well surface) to the top of the fungal biofilm structure. 
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Microphotographs were taken at each focal plan by means of a 
DS-2Mv Nikon digital camera, and the resulting photographs 
were analyzed [Nikon NIS ELEMENTS (version D3.1) software]. 
By manually counting the analyzed steps, the biofilm size was 
evaluated (micrometer); furthermore, by sequentially pulling 
together the acquired optical sections, each biofilm sample could 
be visualized in a movie format.
Candida cell Morphology
Candida albicans morphology has been assessed as previously 
reported (44) with some modifications. Briefly, YL1 and YQ2 yeast 
cells were seeded (1 × 106/ml) in 24-well polystyrene plates with 
plastic cover slips (Thermanox) for 24 h (37°C, 5% CO2). Then, 
the cells were washed three times with PBS and each isolate was 
fixed with 2.5% glutaraldehyde (Electron Microscopy Sciences, 
Hatfield, PA, USA) in 0.1 M phosphate buffer (pH 7.2) for 18 h 
at 4°C. The samples were then carefully washed with 0.1 M phos-
phate buffer (pH 7.2). Post-fixation treatment was carried out for 
1  h at room temperature with 1% osmium tetroxide (Electron 
Microscopy Sciences). Initial dehydration was accomplished by 
placing samples in ethanol as follows: 30% (once for 3 min), 50% 
(once for 6 min), 70% (once for 10 min), 90% (twice for 8 min), 
and 100% (three times for 8 min). The samples were critical point 
dried (Critical Point Dryer, CPD0-10, Balzers, Lichtenstein) 
before being gold coated (Sputter coater K550, Emitech Ltd., 
Ashford, UK) and examined with a scanning electron microscope 
(Nova-NanoSEM 450, FEI Company, OR, USA).
Murine Model of Peritonitis
All experiments involving animals were performed in agreement 
with the EU Directive 2010/63, the European Convention for 
the Protection of Vertebrate Animals used for Experimental and 
other Purpose, and the National Law 116/92. The protocol was 
approved by the Modena and Reggio Emilia University Ethics 
Committee for animal care and use (Organismo preposto al 
benessere degli animali, OPBA). All the animals were housed 
in the animal facility of the University of Modena and Reggio 
Emilia (Authorization number 268/2011A). Female, 6–8 weeks 
old, FVB/N inbred mice (Charles River) were injected intraperi-
toneally with 0.2 ml of 3.5 × 107 CFU/ml C. albicans YL1 or YQ2 
(7 × 106 CFU total), as previously described (45, 46). Eighteen 
hours postinfection, mice were sacrificed and peritoneal cavity 
was lavaged by injection of 4 ml of RPMI-1640, followed by gentle 
massaging of the peritoneal cavity. The peritoneal lavage fluids 
were then centrifuged at 3,000 rpm for 5 min and cellular frac-
tions were suspended in 1 ml of PBS. Aliquots were then used for: 
(a) total cellular counts (by hemocytometer camera), (b) micro-
scopic analysis and phagocytosis assessment (by May Grunwald 
Giemsa staining), (c) CFU evaluation after treatment with Triton 
X-100 (final concentration = 0.2%), (d) cytofluorimetric analysis 
after staining with phycoerythrin (PE) monoclonal antibody to 
mouse GR-1, and (e) evaluation of cytokine/chemokine content 
in the peritoneal lavages by Quantikine ELISA (R&D Systems) 
in duplicate. Kidneys and spleens were also removed, weighed, 
and mechanically homogenized, as previously described, prior to 
CFU analysis (45, 46).
statistical analysis
To determine the statistical significance of the association of a 
particular Gene Ontology term with a list of genes, we referred 
to the indications in http://www.candidagenome.org. The Gene 
ontologies (GO) Term Finder tool on CGD calculates the p-value 
as the probability of having at least a number of genes in the list 
annotated to a particular GO term, given the proportion of genes 
in the whole genome that are annotated to that GO Term. Results 
with a p-value less than 0.05 were considered and included in the 
Figure 1 and Tables S1–S10 in Supplementary Material.
To define statistically significant differences in the sugar cell 
wall composition between strains, Kruskal–Wallis test with False 
Discovery Rate (FDR) correction was performed.
For in vitro and in vivo experiments, statistics was performed 
by one-way ANOVA with Bonferroni correction posttest or by 
the Student’s t-test, using GraphPad Prism (GraphPad Software 
Inc., La Jolla, CA, USA) with *p < 0.05; **p < 0.01; ***p < 0.001; 
****p < 0.0001. In Tables 1 and 2, data are reported as mean ± SD 
(N = 3), in Table 3 as mean values ± SEM (N = 3/group).
resUlTs
Yl1 and YQ2 clinical isolates showed 
Major genetic Variations
A yeast collection of fecal isolates of pediatric CD patients was 
previously characterized phenotypically and genetically (Di 
Paola et  al., submitted). In this study, the genome of the two 
of those clinical isolates, namely YL1 and YQ2, showing major 
genetic variations, was deeply investigated and compared to that 
of the reference C. albicans SC5314 strain. The whole genome-
SNPs-based phylogenetic tree, including the principal fungal 
genera, identified these isolates as C. albicans species (Figure S1 
in Supplementary Material). Analysis of genome-wide variation 
revealed a total of 178.336 SNPs/Indels and 168.981 SNPs/Indels 
for YL1 and YQ2 isolates, respectively, with nucleotide polymor-
phisms in CDS of 43–44%, as compared to the C. albicans SC5314 
reference genome. Heterozygous variants ranged 55–65%, with 
respect to the SC5314 and WO-1 C. albicans references genomes 
(Table S1 in Supplementary Material). Specific homozygous 
regions for both YL1 and YQ2 were identified in chromosome 7 
and in chromosome 2 and 4, respectively (Fig. S2).
Gene ontologies (GO) enrichment analysis showed that 
highly polymorphic genes in YL1 were those related to response 
to nutrients, external stimuli, starvation and genes, involved to 
filamentous growth, while highly mutated genes, common to 
both isolates, include those codifying for cell wall, adhesion, and 
hyphal cell wall categories (Figure 1).
For each sequenced genome, we identified genetic losses by 
comparison with the SC5314 reference genome [operationally, 
we defined an open reading frame (ORF) as “lost gene” with 
at least one region with zero coverage according to reads map-
ping location data; Table S2 in Supplementary Material and 
Section “Materials and Methods”]. We found 20 lost ORFs 
(7 of which were shared by YL1 and YQ2 and six were specific 
for YL1 and 7 for YQ2), which encoded for retro-transposable 
FigUre 1 | Gene ontologies enrichment analysis of the most polymorphic genes. Gene Ontology Term Finder tool on Candida Genome Database were used for 
functional enrichment analysis, using default parameters. Valid results were considered with a p-value <0.05.
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elements and factors involved in biofilm formation (among 
these, HLA21 in both YL1 and YQ2, whereas the ADH3 was 
present only in YQ2).
By comparing sequenced reads across the chromosomes, 
we found genomic regions with copy number variations. We 
identified duplication sites located especially in chromosome 2 
and 6. Among the 11 duplicated ORFs present in both isolates, 
several were retro-elements; one of them, the FGR24 gene, being a 
filamentous growth regulator. Other two members of FGR family 
(FGR13 and FGR14) resulted duplicated in the YL1 genome, as 
TaBle 3 | Parameters assessed in the peritoneal cavity of YL1- and YQ2-
challenged mice.
Total peritoneal cells/
ml (mean ± seM)
PMn/ml  
(mean ± seM)
il-1β (pg/ml) 
(mean ± seM)
Candida 
albicans YL1
5.66 × 106  
± 0.27 × 106
4.92 × 106  
± 0.14 × 106
33.2 ± 6.65*
C. albicans 
YQ2
3.36 × 106  
± 1.18 × 106
3.26 × 106  
± 1.15 × 106
11.1 ± 0.27
The asterisk indicates statistically significant difference comparing C. albicans YL1-
infected mice vs C. albicans YQ2-infected mice (*p < 0.05).
TaBle 1 | Biofilm thickness (expressed as µm) of Candida albicans isolates 
grown in RPMI in presence or absence of fetal bovine serum (FBS).
24 h 48 h
rPMi + 10% FBs rPMi rPMi + 10% FBs rPMi
C. albicans YL1 134 133.5* 182.6* 136.5
C. albicans YQ2 110 14 127 104.5
The asterisks indicate statistically significant differences (*p < 0.05).
TaBle 2 | Biofilm structure and characteristics of Candida albicans isolates 
grown for 48 h in RPMI with fetal bovine serum.
Thickness 
(μm)
number of yeast cells 
released in the biofilm 
supernatants (×104)
number of budding 
yeast cells released 
in the biofilm 
supernatants (×104)
C. albicans 
YL1
168* 19* 6.2*
C. albicans 
YQ2
96.6 5 1.3
The asterisks indicate statistically significant differences (*p < 0.05).
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well as a gene regulated by three iron-responsive transcriptional 
factors (Sef1p Sfu1p and Hap43p), known to be involved in 
C. albicans commensalism and pathogenesis (47). The YQ2 genome 
showed duplication of a member of telomere-associated (TLO) 
gene family (Table S3 in Supplementary Material), known for its 
variability in number and position in C. albicans (12). Furthermore, 
we searched for variants resulting in loss-of-function mutations, 
as SNPs producing internal stop and out-frame insertions or dele-
tions. Across the YL1 and YQ2 genomes, we found 130 and 110 
truncated ORFs, respectively (Tables S4 and S5 in Supplementary 
Material), while Indels resulted in out of-frame mutations that 
disrupted 22 and 16 genes, respectively in the two strains (Tables 
S6 and S7 in Supplementary Material). In the YL1 genome, we 
found prematurely stopped protein-coding genes involved in 
filamentous growth, cellular growth, and response to stimuli. We 
detected as disrupted, genes related to biofilm induction, such as 
EFG1, a key regulator of either the white/opaque switching or fila-
mentous growth and virulence of Candida, whose loss of function 
has been related to increased commensal fitness (12), and GPR1, 
a G-protein-coupled receptor involved in filamentous growth 
and responsive to starvation and regulating HWP1 (hyphal wall 
protein 1) and ECE1 (endothelial converting enzyme 1) genes. It 
is noteworthy that among the 500 more polymorphic genes in our 
strains, ECE1, a gene recently indicated as the main determinant 
of Candida pathogenicity, is highly divergent from the reference 
sequence both in YL1 and YQ2. In particular, in ECE1 gene, 
we found nucleotide polymorphisms generating 27 aminoacid 
(AA) changes in common to YL1 and YQ2 vs SC5314 and WO-1 
C albicans reference strains, and 14 AA changes between YL1 
andYQ2. The following genes associated with known func-
tions (48), were found as truncated in YL1 and YQ2 isolates. 
In particular, the PHR1 (pH responsive), CYR1 (starvation and 
CO2 responsive), SSK2 (responsive to osmotic stress), RFG1 
(repressor of filamentous growth), FLO8 (transcription factor 
involved in hyphal formation and CO2 induced white-opaque 
switching), ALS3 (cell wall adhesion induced and required for 
spider biofilm), VRG4 (a GDP-mannose transporter), SNT1 (a 
transposon mutation affecting filamentous growth), and PDX1 
(a spider biofilm-repressed gene).
Yl1 and YQ2 clinical isolates exhibited 
Phenotypic Differences
A series of phenotypical peculiarities were assessed in YL1 and 
YQ2. First, the ability of the two isolates to form hyphae was 
evaluated under standard culture conditions (i.e., YPD and 
YNB without amino acids and supplemented with ammonium 
sulfate) at 28°C and 37°C. Unlike YL1, YQ2 showed hyphal 
formation after 3 and 7 days, at 37°C, both in YPD and YNB 
media (Figure S3A in Supplementary Material). Second, fun-
gal growth was evaluated in the presence of different carbon 
sources. We found that both isolates showed a significant 
lower growth rate in media with non-fermentable carbon 
sources, namely, 2% of glycerol, ethanol, or oleate (Figure S3B 
in Supplementary Material). Third, we exposed YL1 and YQ2 
to the oxidative stress induced by tert-butyl hydroperoxide 
treatment, as detailed in Section “Materials and Methods.” 
We found that the YL1 was more susceptible to the oxidative 
stress than YQ2 and SC5314 reference strain (Figure S3C in 
Supplementary Material). Fourth, we investigated the suscep-
tibility to Ketoconazole and Fluconazole, two fungicidal agents 
known to interfere with the synthesis of fungal cell membrane. 
We found that both isolates showed resistance to Fluconazole, 
while only the YQ2 was resistant to Ketoconazole (Figure S4 in 
Supplementary Material).
Then, we tested the ability of the isolates to form biofilm in 
RPMI, in presence or absence of FBS and CO2, factors known to 
influence biofilm formation [(49, 50), p. 8 (51)]. Both YL1 and YQ2 
isolates produced biofilm after 48 h of incubation, irrespectively 
of the presence of FBS; nevertheless, the thickness of YL1 biofilm 
was significantly higher than that produced by YQ2 (Table  1). 
Noteworthy, YQ2 did not produce biofilm at 24 h in the absence 
of FBS (Table 1); also CO2 markedly influenced biofilm formation 
by YQ2, which was indeed delayed in the absence of CO2 (data 
not shown). Furthermore, by investigating the morphological 
characteristics of the 48 h-old biofilms, we found marked differ-
ences in thickness mirrored by different cellular structures. As 
shown in Table 2, the number of both yeasts and budding yeast 
cells released by YL1 biofilm was significantly higher compared 
to that released by YQ2 biofilm.
FigUre 3 | YL1 and YQ2 isolates showed different sugar cell wall 
composition. Sugars’ composition has been assessed on YL1 and YQ2 cell 
culture in RPMI in presence or absence of 10% fetal bovine serum and 5% 
CO2. Mean of three independent replicates is shown. *p < 0.05, YL1 glucose 
content vs YQ2 glucose content in the same cultural condition. **p < 0.01, 
YL1 mannose content vs YQ2 mannose content in the same culture 
conditions.
FigUre 2 | Kinetic analysis of biofilm morphology. To examine cell morphology, Candida albicans cells were seeded for 3 an 24 h at 37°C under 5% CO2. After 
fixation with 2.5% glutaraldehyde, cells were exposed for 1 h at room temperature with 1% osmium tetroxide. The samples were critical point dried before being 
gold coated and examined with a scanning electron microscope.
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Finally, kinetic studies on the occurrence of dimorphic transi-
tion showed that after 3  h, both isolates formed long hyphae; 
interestingly, only the YL1 maintained also several budding yeast 
cells. At 24 h, the YL1 biofilm showed a particularly dense hyphal 
structure with interspersed germinating yeast cells that were not 
detectable in YQ2 biofilm (Figure 2).
Yl1 and YQ2 Differed in cell Wall sugar 
components
Sugars’ moieties and their exposure on fungal cell wall are deter-
minant for Candida morphological switching and its ability to 
adhere to epithelial cells, escape immune system, and spread into 
host tissues (52). Therefore, we explored the YL1 and YQ2 isolates 
in terms of a possible diversity in cell wall composition. The cell 
wall of two isolates differed in terms of mannan and glucan con-
tent. In particular, YQ2 strain had higher mannan levels, while 
YL1 had more glucan in their cell wall. These differences were 
maintained in the different growth conditions, irrespectively of 
the fact that cultures had been performed with or without FBS 
and CO2 (Figure 3).
comparative Transcriptional analysis on 
Yl1 and YQ2 isolates during Biofilm 
Formation
With the aim to investigate the transcriptional reprogramming 
in the two isolates, we performed a transcriptional analysis on 
YL1 and YQ2 cultured at 37°C in RPMI both in presence and 
absence of 10% FBS (Figure 4). Operationally, we collected cells 
after 1 and 24  h of incubation. Since the analysis showed that 
several DEGs differentiated YL1 from YQ2 irrespectively of the 
presence of FBS, we herein describe only this comparison, but 
the complete analysis is reported in Tables S8–S10 and Figure S5 
in Supplementary Material. We found 414 DEGs (approx. 10% 
of Candida genome) differencing YL1 and YQ2 transcriptional 
program after 1 h (151 up, 263 down; logFC < −1, logFC > 1, 
FDR < 0.05) (Tables S8 and Figure S5 in Supplementary Material). 
Interestingly, a lower number of genes were differentially 
expressed after 24 h; out of 273 DEGs, 110 were upregulated and 
163 downregulated (Table S8 in Supplementary Material). It is 
noteworthy that seven genes, involved to some degree in biofilm 
formation, were downregulated after 1 h and upregulated after 
24 h (Table S8 in Supplementary Material, YL1 vs YQ2).
FigUre 4 | YL1 and YQ2 isolates showed different transcriptional regulation during biofilm formation. Heatmap visualization supported by hierarchical clustering 
(obtained using distance metric selection by Pearson correlation and average linkage clustering methods) of the gene differentially expressed in at least two 
condition. The complete list of differentially expressed genes is present as Table S8 in Supplementary Material.
10
Cavalieri et al. Pathogenic Strategies of C. albicans
Frontiers in Immunology | www.frontiersin.org January 2018 | Volume 8 | Article 1997
FigUre 5 | YL1 and YQ2 isolates differed in their ability to adhere to 
epithelial cells. Caco-2 cells were seeded in Lab-Tek II chamber slides, grown 
at 37°C to confluence (24 h) and then infected with a suspension of Candida 
in complete RPMI for 1.5 or 3 h at 37°C under 5% CO2. Uvitex 2B 
fluorescence of bound C. albicans was visualized by epifluorescence 
microscopy. At least 200 epithelial cells from each sample were examined 
and the percentage of Caco-2 cells with adherent yeasts was defined as the 
ratio of the number of Caco-2 cells with one or more C. albicans to the total 
number of Caco-2 cells examined. Data are represented as mean ± SD 
(N = 3). *p < 0.05.
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Looking at specific DEGs, YL1 upregulated the CDC28 gene 
(logFC =  1.23; Table S8 in Supplementary Material), which is 
known to be involved in cell morphology and biofilm formation 
(53, 54). Moreover, even if YL1 had a stop codon mutation in 
GPR1, its transcript resulted upregulated at 1 h (logFC = 1.24) 
(Table S8 in Supplementary Material), differential expression of 
the ALS genes (55, 56), known to be involved in cell–cell or host 
cell adhesion and invasive growth, was also observed. Compared 
to YQ2, YL1 upregulated ALS7 gene (logFC = 1.03; Table S8 in 
Supplementary Material), while this gene was not differentially 
expressed later on, suggesting that adhesion and biofilm forma-
tion are the initial stages of adaptation.
Biofilm formation is known to be induced by stress genes 
(i.e., CDR genes) (55, 56); in our hands, YL1 showed down-
regulation of an important member of this family, CDR4 after 1 h 
(log FC = −1.44) and its overexpression at 24 h (log FC = 1.14).
Increased production and secretion of proteins with agglutina-
tion properties may favor the cell cohesion within the biofilm. The 
transcriptional analysis showed that despite an initial upregula-
tion of some components of the secretion machinery (SEC3 and 
SEC6, Table S8 in Supplementary Material), which could account 
for the higher thickness of YL1 biofilm, YQ2 upregulated other 
genes involved in biofilm development, SEC53, SEC21, SEC22, 
SEC61, SEC32, SEC17, SEC24, at 24 h. Also lipid metabolism, 
membrane trafficking, and production of secretory vesicles 
from Golgi to endoplasmic reticulum (and vice versa), seemed 
to be differently affected in the two isolates (Tables S9 and S10 in 
Supplementary Material). Based on the DEG lists, we performed 
a functional enrichment over GO biological process categories 
and over FunCat categories and KEGG pathways, using DAVID 
tool (33) and the fungal specific FungiFun 2.0 tool (34). The 
comparison of the biological function enrichments allowed to 
identify processes differently affected during biofilm formation 
by YL1 and YQ2 isolates (Tables S9 and S10 in Supplementary 
Material). In particular, at 1  h, response to stress, organelle 
organization, as well as hyphal development, were functional 
enriched in the YL1 isolate with respect to YQ2. After 1 h, YL1 
downregulated part of the amino acid biosynthesis genes, some 
involved in sulfur amino acid biosynthetic pathways (Table S10 
in Supplementary Material, FunCat enrichment, p =  0.0035), 
known to affect the biofilm formation, as well as the metabolism 
of branched amino acids, like glutamate and aspartate (Table 
S10 in Supplementary Material, KEGG pathway enrichment, 
p  =  0.03). Interestingly, YL1 showed a downregulation of 
cell wall biogenesis (p =  0.0060, Table S9 in Supplementary 
Material) and assembly (p = 0.00029, Table S9 in Supplementary 
Material), as soon as 1 h of incubation while after 24 h it showed 
a downregulation of cell wall mannoprotein biosynthesis 
pathways (p =  0.016, Table S10 in Supplementary Material), 
and an increased regulation of β-glucan biosynthetic processes 
(p  =  0.0075, Table S10 in Supplementary Material), further 
corroborating the differences in cell wall composition observed 
between YL1 and YQ2. Interestingly, after 24 h, YL1 upregulated 
carnitine (Table S9 in Supplementary Material, p = 0.031) and 
acetyl-CoA (Table S10 in Supplementary Material, p = 0.049) 
metabolism, a process well known for promoting biofilm forma-
tion and fungal pathogenesis (57).
At 24 h, YQ2 upregulated genes involved in RNA processing 
and transcription regulation, as well as several genes involved in 
biosynthesis or salvage of nucleosides and translation (Table S9 in 
Supplementary Material). These cellular activities might be used 
by YQ2 in biofilm progression, for the production of extracellular 
matrix, which was not present in the bouquet-like structures of 
YL1 biofilm, which showed presence of budding and planktonic 
cells also at 24 h.
Yl1 and YQ2 Differently interacted with 
human epithelial cells
We investigated the capacity of the two isolates to adhere to and 
to affect secretory response of human epithelial cells, by using the 
intestinal Caco-2 cell line. We found that the percentage adhesion 
was significantly higher with YL1 compared to YQ2 (Figure 5). 
Moreover, experiments were performed to determine whether 
Caco-2 cells challenged for 24 h with YL1 and YQ2 were affected 
in their human beta-defensin 2 (HBD-2) production; as shown in 
Figures 5, HBD-2 levels were significantly lower in Caco-2 cells 
exposed to YL1 that to YQ2 (47 vs 67 pg/ml, respectively). These 
results indicate that, although having a higher ability to bind to 
intestinal epithelial cells, YL1 induced lower HBD-2 response, 
compared to YQ2, thus further arguing on relevant differences 
between these two isolates in terms of pathogenic potential.
Yl1 and YQ2 elicited Different responses 
by human PBMc
Human PBMC were tested for cytokine response to YL1 and 
YQ2 Candida isolates, as described in Section “Materials and 
Methods.” Both clinical isolates induced a pro-inflammatory 
response (Figure  6A), but they differed in inducing cytokines 
related to the adaptive immune response. In particular, while YL1 
FigUre 6 | Peripheral blood mononucleated cells (PBMCs)’ cytokine response to YL1 and YQ2 infection. PBMC were exposed to Candida YL1 and YQ2 isolates 
(E:T = 1:10) for 5 days. Then, supernatants were harvested and assessed for innate (a) and adaptive (B) cytokine levels, as detailed above. Data are represented as 
mean ± SD. *p < 0.05, YL1 vs YQ2; **p < 0.01, YL1 vs YQ2. US indicates unstimulated cells.
FigUre 7 | YL1 and YQ2 isolates differently resisted to microglial cell-mediated antifungal activity. (a) Susceptibility of the YL1 and YQ2 isolates to phagocytosis 
was assessed by epifluorescence microscopy using BV2 microglial cells. Oregon green 488 prelabelled yeast cells were exposed to BV2 cells (E:T = 1:5) for 1.5  
and 3 h. At each end point, Uvitex 2B was added for 15 min; the cultures were then washed, fixed, and analyzed by epifluorescence microscopy. The percent of 
phagocytic cells was calculated as detailed in Section “Materials and Methods.” Data are shown as mean ± SD (N = 3). (B) Susceptibility of YL1 and YQ2 isolates 
to antifungal activity by microglia. Yeast cells were exposed to BV2 cells at E:T = 10:1. After 3, 6, and 20 h, the percent of antifungal activity was determined as 
detailed in Section “Materials and methods.” Data are shown as mean ± SD (N = 43). *p < 0.05, YL1 vs YQ2. (c) Acidification of phagolysosomes containing YL1 
and YQ2 cells. Oregon green 488 prelabelled yeast cells were exposed to BV2 cells (E:T = 1:5); then, LysoTraker dye was added. After counterstaining with Uvitex 
2B, samples were fixed and then visualized by epifluorescence microscopy. Representative images of acidification of phagolysosomes by means of epifluorescence 
are shown. (D) Percent of acidic phagolysosomes, containing YL1 or YQ2 cells. The values were calculated by evaluating the number of red-stained vacuoles 
among 200 yeast-containing vacuoles. Data are shown as mean ± SD (N = 3). *p < 0.05, YL1 vs YQ2.
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induced a strong production of IFN-γ, YQ2-challenged PBMC 
responded to the fungus by releasing IL-17 (Figure 6B). These 
findings underlined the diversity between YL1 and YQ2 also in 
their interaction with host first line defenses, such as PBMC.
Yl1 and YQ2 Differential susceptibility  
to Phagocyte-Mediated host Defenses 
In Vitro and In Vivo
We performed in vitro studies to characterize the interaction of 
YL1 and YQ2 clinical isolates with tissue derived phagocytes; 
particularly, the murine microglial cell line BV2 was chosen as 
an efficacious prototype of brain macrophages (26–28, 38, 41, 
42). Using a previously established fluorescence-based assay 
(42), we measured YL1 and YQ2 susceptibility to phagocytosis, 
by evaluating number of BV2 cells that had ingested the yeast 
cells, at 1.5 and 3 h postinfection. As shown in Figure 7A, both 
isolates were efficiently engulfed by phagocytes, in a similar and 
time-dependent manner.
Next, we examined the ability of the two isolates to survive 
within phagocytes. To this aim, a modified protection assay was 
performed (42). BV2 cells were challenged with YL1 or YQ2 yeast 
cells for 1.5 h and then the non-ingested yeast cells were removed. 
Subsequently, the residual fungal load was determined immedi-
ately (time 0) or 3, 6, and 20 h later. We found that up to 6 h, 
the number of CFU recovered from BV2 cells remained stable by 
the time and was similar in the two isolates. In contrast, at 24 h, the 
intracellular CFU of YL1 greatly increased, reaching more than 
threefold higher levels than those observed with YQ2 (p < 0.05) 
(Figure 7B). These data indicated a relevant difference between 
YL1 and YQ2, in terms of susceptibility to phagocyte-mediated 
defenses.
To further investigate the events occurring after YL1 and 
YQ2 yeast cell ingestion, acidification of fungal cell-containing 
phagosomes was assessed, as detailed elsewhere (58). Briefly, YL1 
and YQ2 yeast cells were incubated for 1 and 3 h with BV2 cells in 
the presence of LysoTracker, a marker of phagosome acidification 
(see Materials and Methods). Then, fluorescence microscopical 
examination was performed. Overlapping pictures obtained 
with different fluorescence channels were used to evaluate the 
successful acidification of Candida-containing phagosomes 
[simultaneous appearance of LysoTracker (red fluorescence) and 
unlabeled yeasts within the phagosomes] (Figure 7C). Then, we 
calculated the percentage of acidic phagosomes by counting the 
Candida-containing phagosomes within each BV2 cell. As shown 
in Figure 7D, after 1.5 h, the percentage of acidic YQ2-harboring 
phagosomes was higher than that of YL1-containing phago-
somes. Indeed, about 18% of the YQ2 were associated with acidic 
phagolysosomes, while this percentage remained around 9% in 
the case of YL1 yeast cells; similar results were also observed after 
3 h. In both cases, the differences between YQ2 and YL1 were 
statistically significant (p < 0.05). Taken together, this evidence 
implies that YL1 resists to phagocyte-mediated intracellular kill-
ing by inhibiting phagosome maturation much better than YQ2.
Finally, to investigate the in vivo virulence of the two isolates, 
a comparative study was performed by a mouse model of intra-
peritoneal infection. As detailed above, 7 × 106 Candida/mouse 
were injected in the peritoneal cavity of mice, at time 0; 18 h later, 
the animals were sacrificed, and several parameters assessed. As 
depicted in Table  3, the number of host cells recovered in the 
peritoneal cavity of YL1-challenged mice was higher than that 
obtained from the YQ2-infected counterpart; also, the number 
of polymorphonuclear leukocyte (PMNs; GR-1 positive cells) 
followed the same trend. The levels of IL-1β detected in the peri-
toneal lavage of YL1-infected mice were significantly higher than 
those observed in YQ2-infected counterpart (Table 3), while little 
or no differences were found in terms of TNF-α and MCP1 (data 
not shown). Furthermore, significant differences were observed 
when assessing the ability of peritoneal exudate cells to ingest 
Candida, by microscopic analysis; a sixfold higher phagocytic 
activity was observed in YQ2-infected animals, with respect to 
YL1-infected animals. When evaluating the CFU in the organs, 
no statistically significant differences were observed between the 
two groups of mice; yet, YL1 CFU were slightly less detected in 
the peritoneal lavages and more in the spleens (data not shown).
DiscUssiOn
Host defense against disseminated Candida infection primarily 
relies on the ability of professional phagocytes to ingest and rap-
idly destroy fungal cells, via phago-lysosome fusion, by cytocidal 
factors within an acidic environment that fulfill intracellular 
killing (a process known as “phagosome maturation”) (59). 
Nevertheless, C. albicans has evolved several strategies to escape 
such first line host-mediated defenses (60, 61). In particular, the 
morphogenetic status of the fungus finely affects macrophage-
mediated effector and secretory response to the infection (62–64). 
Even more, fungal cells ensure their persistence and propagation 
within phagocytes, by affecting cytokine response and altering 
recruitment of late endocytic/lysosomal compartments (65, 66). 
Yet, the pathogenic mechanisms and relative attributes involved 
in C. albicans infection and colonization are still not completely 
understood. It is generally recognized that C. albicans virulence is a 
multifactorial peculiarity driven by genome plasticity (13–15, 40), 
namely its ability to efficiently adapt to different environments 
and deftly coordinate the expression of certain virulence genes 
(45–48, 67, 68). As an example, while disseminated candidi-
asis is mainly induced by the yeast form, mucosal diseases are 
attributed mostly to filamentous forms, like invasive hyphae and 
pseudohyphae (66).
In the present work, we show that two distinct C. albicans 
clinical isolates, obtained from CD patients, differ significantly 
from the reference genome, and also from each other. The major 
genetic variants differentiating the two strains are in genes 
related to biofilm production and susceptibility to first line host 
barriers, and correlate significantly to isolate-specific phenotypic 
differences. In line with the present findings, we have previously 
provided initial evidence that C. albicans isolates with distinct 
genotypic profiles (b and c karyotypes) exhibit different virulence 
profile (69); specifically, differences between b and c isolates have 
been observed in terms of ability to undergo morphological 
transition and to resist to macrophage-mediated intracellular 
killing (70). Here, the whole genome sequencing of two clinical 
isolates from CD patients (YL1 and YQ2) reveals a great number 
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of highly polymorphic genes in comparison with the reference 
SC5314 C. albicans strain. Interestingly, polymorphic genes code 
for factors influencing fungal external structure, cell wall com-
position, fungal-type cell wall, hyphal cell wall determinants, and 
cell adhesion, suggesting increased variability in morphogenetic 
pathways. Furthermore, we identified variants resulting in gain- 
or loss-of-function mutations. Among such genes, we have found 
several regulators induced in response to environmental signals, 
like the response to pH, O2/CO2, as well as some repressors of 
yeast filamentation (48).
By assessing YL1 and YQ2 ability to undergo transition from 
yeast to hyphal form, we found that the former produces biofilm 
more rapidly than the latter. The structural and morphological 
analysis of their biofilms highlights substantial differences, in 
that, YQ2 biofilm is composed primarily of hyphal cells, while 
YL1 biofilm is characterized by a high-density hyphal structures 
with several interspersed germinating yeasts. It is well established 
that biofilm formation allows invading pathogens to create a safe 
sanctuary, in which sessile cells remain in a protected environ-
ment (2, 71, 72). Conversely, biofilm embedded-cells may be 
even limited by adverse conditions, such as a reduced nutrient 
availability; because of this, dispersion/detachment of cells would 
be beneficial to microbial survival. In addition, the release of 
cells from biofilm allows metastatic spreading and generation of 
novel communities at new locations [a mechanism reviewed in 
Ref. (73)]. This mechanism is particularly relevant in the case of 
C. albicans, since spreading cells, in yeast form, are responsible 
for candidemia and disseminated invasive candidiasis (74–77). 
In our hands, the number of both yeasts and budding yeast cells 
released by YL1 biofilm is significantly higher compared to that of 
YQ2 biofilm; this in vitro finding suggests that YL1 may have an 
increased virulence potential compared to YQ2 isolate.
Strikingly, the genomic and phenotypic differences between 
YL1 and YQ2 are corroborated by differences in gene expression. 
The causal relation between gene expression changes and the 
genetic differences cannot be determined based on our results, 
yet, the significant difference in gene expression are observed at 
early times (1  h), thus making unlikely that these changes are 
caused by differences in the structure of the hyphal mat or nutri-
ent availability, which would be expected at later time points. 
Several examples support the driving role of genetic differences 
in explaining differential gene expression associated to yeast-to-
hyphal form transition and biofilm formation. In one hand, at 
the pathway level, YL1 downregulates amino acid biosynthesis 
genes, in particular, sulfur amino acid biosynthetic pathways, 
known to induce the biofilm formation, as well as the metabo-
lism of branched amino acids, like glutamate and aspartate. YL1 
shows a downregulation of cell wall biogenesis as soon as after 
1 h of incubation, while after 24 h a downregulation of cell wall 
mannoprotein biosynthesis pathways occurs, together with an 
increased regulation of β-glucan biosynthetic processes, further 
corroborating the differences in cell wall composition observed 
between YL1 and YQ2, especially in terms of mannan and glucan 
content. On the other hand, at the single gene level, YL1 shows a 
significantly increased expression of GPR1, despite having a stop 
codon mutation in the ORF of the gene; this finding suggests 
that the interrupted gene is expressed but is then translated as 
a sub-functional protein, thus interfering as a negative feedback 
loop in the control of its own expression (a condition likely not 
occurring in YQ2). Notoriously, GPR1 encodes a plasma mem-
brane G-protein-coupled receptor of the cAMP-PKA pathway, 
which triggers the signaling pathway that in turn regulates 
β-glucan masking, immune evasion, and hyphal growth through 
interaction with GPA2 and regulation of HWP1 and ECE1 (78). 
Moreover, ECE1 encodes for the hyphal borne toxin named can-
didalysin, known to directly damage epithelial membranes, via a 
danger response signaling pathway and epithelial cell activation. 
As a counterpart, C. albicans strains lacking this toxin do not 
activate or damage epithelial cells, and are avirulent in animal 
models of mucosal infection (79). In our hands, YL1 and YQ2 iso-
lates show a significant divergence in candidalysin gene, further 
suggesting that different strategies of adaptation to the host have 
indeed occurred in the two isolates (likely also via occurrence 
of ECE1/candidalysis variants). Recent evidence highlighted that 
C. albicans isolates showing diverse pathogenicity in an oral infec-
tion model does not show differences in ECE1 expression when 
exposed to keratinocytes (9), yet, this cannot exclude that ECE1 
driven differences in pathogenicity are associated to differences 
in protein function, thus suggesting the importance to obtain 
protein sequence in addition to gene expression information.
Of course, transcriptional differences observed at 24 h could 
be due to the specific features of the biofilms and different avail-
ability of nutrients and oxygen; as an example, YL1 upregulates 
carnitine and acetyl-CoA metabolism, a process well known for 
promoting biofilm formation and fungal pathogenesis (57).
These findings are in line with the diversity in yeast cell:hyphal 
cell ratio observed in their respective biofilm structures and cor-
relate with the different adhesion ability of the two isolates.
The higher ability of YL1 to adhere to human intestinal cells 
in vitro further argues on the enhanced pathogenic potential of 
this clinical isolate, in agreement with previous findings show-
ing that short germ tubes are more adherent than hyphae (79). 
Additionally, YL1 isolate induces lower levels of HBD-2; since 
this defensin exerts potent anti-C. albicans effects (80–82), we 
may interpret the minor YL1-induced secretory response as an 
additional mechanism to locally limit host innate immune reac-
tion and in turn Candida pathogenicity.
The in  vivo data provide initial evidence that indeed YL1 
evokes a more pronounced inflammatory response than YQ2, as 
indicated by the higher peritoneal cell recruitment, PMN influx 
and local IL-1β response. Nevertheless, the efficacy of peritoneal 
cells to ingest Candida appears to be significantly lower in YL1 
than in YQ2-infected mice, thus strongly suggesting that the 
former has the capacity to promptly evade first line host defenses. 
The CFU/organ measured at 18 h do not allow revealing signifi-
cant differences between the two isolates in terms of dissemina-
tion through the host. Certainly, more in depth and dedicated 
studies are necessary to fully understand the in vivo pathogenic 
profile of the two isolates. In conclusion, our results suggest that 
C. albicans has a complex system of chronologically arranged 
processes by which morphological changes and adaptation to the 
host are driven; as expected, in agreement with previous findings 
(49, 83), serum is a potent stressor for Candida. Our observa-
tions indicate that the genetic features of YL1 allow it to faster 
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adapt to environmental changes with respect to YQ2. On these 
bases, YL1 biofilm, particularly rich in yeast and budding cells, 
may be interpreted as a condition to better disseminate into the 
host. Further, the finding that the improvement of the YL1 phe-
notype requires inactivation of morphogenetic switch pathways 
suggests that the morphogenetic switch is a mechanism required 
for commensalism rather than pathogenesis. We, therefore, 
hypothesize that evolution shapes Candida genomic adaptation 
to the invasive phenotype by hampering important controllers of 
the morphogenetic switch; the functional effects of the concerted 
set of mutations discovered is in fact reflected by transcriptomic 
differences significantly affecting pathways involved in cell wall 
composition and filamentation. These mutations apparently 
negatively influence the ability of professional phagocytes to 
ingest and clear the engulfed yeast cells. The latter observation is 
supported by the fact that, albeit similarly internalized, the YL1 
isolate is able to resist to intracellular killing better that YQ2, by 
inhibiting phagosome maturation within phagocytes in  vitro; 
even more, YL1 can survive and replicate inside microglial cells, 
thus potentially taking further pathogenic advantage by the so 
called “Troy horse” phenomenon.
Overall, we demonstrate that phagocyte response to 
C. albicans is an isolate-dependent reaction; in particular, 
genomic background and adaptation to host environment 
deeply affect not only susceptibility to phagocytic defenses but 
also fungal cell wall composition as well as biofilm morphology. 
The present findings add further insights on the knowledge 
that virulence phenotype of C. albicans has to be multifactorial, 
possibly due to numerous, putative virulence tracts that may 
synergistically and/or differentially contribute to the multistep 
pathogen–host interplay, ultimately affecting the outcome 
of the infection. Whether these in  vitro data will have an in 
patients counterpart has yet to be established. We may envisage 
that the different ability of the two isolates, YL1 and YQ2, to 
switch between yeast-to-hyphal morphologies, interact with 
epithelial cells and resist to phagocytes might have played a 
role in the onset and progression of the inflammatory process 
commonly present in bowel disease. The preliminary data, 
observed in the peritoneal infection model in mice, strongly 
argue on the different virulence of the two isolates. As detailed 
above, these isolates derived from CD patients, in which a 
pathologic interplay between host immune system and com-
mensal organisms occurs. Accordingly, several studies indicate 
that C. albicans infections originate from commensal strains 
and that virulence-related traits may emerge as consequence 
of an impaired host immunity. Notoriously, the pathogenesis 
of CD is based on a genetically determined loss of immune 
tolerance to luminal antigens, in turn initiating an uncontrolled 
inflammatory process (84). Among the wide range of microbial 
antigens supporting an abnormal immune response to CD, yeast 
antigens have been described (85), as well as anti-Saccharomyces 
cerevisiae antibodies are detected as markers of CD; we cannot 
exclude that, because of common antigens, also Candida may 
act as endogenous immunogen, participating to the aberrant 
immune response in CD (86). We thus conclude that the co-
occurrence of stop codon and missense mutations in pathways 
driving dimorphic transition and host infection reflects a selec-
tive balance between traits favoring yeast form dissemination 
and mucosal penetration, which in turn may depend on gut bar-
rier permeability and immune system of the host environmental 
niches where the strain has evolved. Thus, to better understand 
the impact of fungi on host’s immune system, it is of increasing 
importance to investigate both the phenotypic and genomic 
characteristics at single isolate level, in multiple isolates, as well 
as to unravel the fine mechanism driving host cell–pathogen 
interaction.
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